R42 Group

Palo Alto, United States
Venture Capital
Active
Total investments

26

Average round size

4M

Portfolio companies

18

Lead investments

1

Follow on index

0.31

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceHealth CareMedicalDigital MarketingLife SciencePharmaceuticalDigital Media

Investor highlights

Industry focus
AI/Big DataBiotech/Life SciencesTelecommunicationsAnalyticsIoT Show 1 more
Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
26
Lead investments
1
Follow on index
0.31
Investments by industry
  • Biotechnology (16)
  • Health Care (8)
  • Information Technology (5)
  • Pharmaceutical (5)
  • Life Science (4)
  • Show 24 more
Investments by region
  • United States (5)
  • United Kingdom (17)
  • Switzerland (2)
  • Austria (2)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
304K
Group Appearance index
0.96

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
Bounce Imaging02 May 2022Robotics, Hardware, Video, Consumer Electronics, Sensor, Law EnforcementEarly Stage Venture4MUnited States, Massachusetts, Boston
Senisca18 Mar 2024BiotechnologySeed5MEngland, Exeter, United Kingdom
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.